Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 28:11:62.
doi: 10.1186/1742-2094-11-62.

Role of the TLR4 pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia/reperfusion injury in rats

Affiliations

Role of the TLR4 pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia/reperfusion injury in rats

Xiao-Qian Li et al. J Neuroinflammation. .

Abstract

Background: Spinal cord ischemia-reperfusion (I/R) involves two-phase injury, including an initial acute ischemic insult and subsequent inflammatory reperfusion injury, resulting in blood-spinal cord barrier (BSCB) dysfunction involving the TLR₄ pathway. However, the correlation between TLR₄/MyD₈₈-dependent and TLR₄/TRIF-dependent pathways in BSCB dysfunction is not fully understood. The aim of this study is to characterize inflammatory responses in spinal cord I/R and the events that define its clinical progression with delayed neurological deficits, supporting a bimodal mechanism of injury.

Methods: Rats were intrathecally pretreated with TAK-242, MyD₈₈ inhibitory peptide, or Resveratrol at a 12 h interval for 3 days before undergoing 14-minute occlusion of aortic arch. Evan's Blue (EB) extravasation and water content were detected at 6, 12, 18, 24, 36, 48, and 72 h after reperfusion. EB extravasation, water content, and NF-κB activation were increased with time after reperfusion, suggesting a bimodal distribution, as maximal increasing were detected at both 12 and 48 h after reperfusion. The changes were directly proportional to TLR₄ levels determined by Western blot. Double-labeled immunohistochemical analysis was also used to detect the relationship between different cell types of BSCB with TLR₄. Furthermore, NF-κB and IL-1β were analyzed at 12 and 48 h to identify the correlation between MyD₈₈-dependent and TRIF-dependent pathways.

Results: Rats without functional TLR₄ and MyD₈₈ attenuated BSCB leakage and inflammatory responses at 12 h, suggesting the ischemic event was largely mediated by MyD₈₈-dependent pathway. Similar protective effects observed in rats with depleted TLR₄, MyD₈₈, and TRIF receptor at 48 h infer that the ongoing inflammation which occurred in late phase was mainly initiated by TRIF-dependent pathway and such inflammatory response could be further amplified by MyD₈₈-dependent pathway. Additionally, microglia appeared to play a major role in early phase of inflammation after I/R injury, while in late responding phase both microglia and astrocytes were necessary.

Conclusions: These findings indicate the relevance of TLR4/MyD₈₈-dependent and TLR₄/TRIF-dependent pathways in bimodal phases of inflammatory responses after I/R injury, corresponding with the clinical progression of injury and delayed onset of symptoms. The clinical usage of TLR₄ signaling inhibitors at different phases may be a therapeutic option for the prevention of delayed injury.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Time dependent progression of BSCB permeability changes after spinal cord ischemia/reperfusion (I/R) injury. (A) Effects on Evans blue (EB) extravasation in the Sham and I/R groups along the entire time course from 6 to 72 h after surgery. I/R-induced a significant increase in EB extravasations at each observed time point, with the greatest intensity at 12 and 48 h, especially in the gray matter. Scale bars = 200 μm. (B) Quantification of EB content of the spinal cord (μg/g). (C)  Quantification of the water content of the spinal cord. All data are represented as means ± SEM (n = 8 per group). *P < 0.01 vs. Sham group.
Figure 2
Figure 2
Time course of TLR4 activation in the spine after I/R injury. (A) Representative immunofluorescence of TLR4. Prominent TLR4 immunoreactivation was observed in both dorsal horns of the spinal cord in operated rats. Spinal cord I/R-induced TLR4-up regulation increased with time and peaked at 12 and 48 h after surgery. Scale bars = 100 μm for the 100× and 50 μm for the 400× images. (B) Representative Western blot analysis and integrated density values (IDVs) of TLR4 activation. The IDVs of TLR4 in the I/R group with different reperfusion time points were calculated after normalizing against the Sham group and presented as relative protein expression units. The maximal of IDVs were observed at 12 and 48 h after surgery. All data are represented as means ± SEM (n = 8 per group). *P < 0.05 vs. Sham group.
Figure 3
Figure 3
Blocking effects of specific binding protein on TLR4, MyD88, and TRIF protein. (A-C) Representative Western blot analysis of TLR4, MyD88, and TRIF protein in L4–6 segments of spinal cord at 12 and 48 h after I/R injury. (D-F) The integrated density values (IDVs) in each group with different reperfusion time points were calculated after normalizing against β-actin and presented as relative protein expression units. Data are presented as means ± SEM (n = 8 per group). **P < 0.01 vs. Sham group; ## P < 0.01 vs. I/R group.
Figure 4
Figure 4
Double-labeled immunofluorescence TLR4 receptor and specific cell population in blood spinal cord barrier after spinal cord I/R injury. (A) Representative immunohistochemical localization of capillary endothelial cells (CD31; green), pericytes (CD13; green), microglia (Iba-1; green), astrocytes (GFAP; green), and Toll-like receptor (TLR4; red) in spinal cords of sham-operated or operated rats at 12 and 48 h after the surgical procedure, respectively. Scale bars = 100 μm for the 200× images. (B) Effects of TLR4 signaling on TLR4 co-localization cells. Representative double-labeling micrographs show that intrathecal pretreatment with TAK-242, MIP, and Resveratrol before I/R injury significantly prevented microglia and astrocytes upregulated expression of TLR4 at 48 h after the surgery. Scale bars = 50 μm for the 400× images. (C) Quantification of TLR4-positive microglia and TLR4-positive astrocytes in the spinal cords. Data are presented as mean ± SEM (n = 6). **P < 0.01 vs. Sham group; ## P < 0.01 vs. I/R group; &&P < 0.05 vs. TAK group.
Figure 5
Figure 5
Effects of TLR4 signaling on BSCB dysfunction after I/R injury. (A) Representative EB dye after intrathecal injection with TAK-242, MIP, and Resveratrol. Almost no red fluorescence was seen in spinal cord parenchyma in the Sham group at 12 and 48 h after injury. Much more red fluorescence could be seen in the I/R and Resveratrol groups at 12 h. These increased in intensity at 48 h in all groups after injury, especially in the gray matter of the I/R and MIP groups. Minimal EB red fluorescence was seen in the Sham and TAK groups at the above two time points. (B) Quantification data of EB content of spinal cord (μg/g). (C) Quantification of the water content of the spinal cord. All data are represented as mean ± SEM (n = 8 per group). Scale bars = 50 μm for 100× images. **P < 0.01 vs. Sham group; ## P < 0.01 vs. I/R group; &&P < 0.05 vs. TAK group.
Figure 6
Figure 6
Effects of TLR4 signaling on NF-κB activation and inflammatory cytokines after I/R. (A) Representative Western blot and quantitative protein analysis of NF-κB in the spinal cord at 12 and 48 h after intrathecal pretreatment with TAK-242, MIP, and Resveratrol for 3 days. (B) The relative integral density values were calculated after normalizing against β-actin in each sample. (C) Quantification of IL-1β production in spinal cord at 12 and 48 h after I/R injury, as assessed by ELISA. **P < 0.01 vs. Sham group; ## P < 0.01 vs. I/R group; &&P < 0.05 vs. MIP group.

References

    1. Bell MT, Puskas F, Agoston VA, Cleveland JC Jr, Freeman KA, Gamboni F, Herson PS, Meng X, Smith PD, Weyant MJ, Fullerton DA, Reece TB. Toll-like receptor 4-dependent microglial activation mediates spinal cord ischemia-reperfusion injury. Circulation. 2013;128(1):S152–S156. - PubMed
    1. Zhu P, Li JX, Fujino M, Zhuang J, Li XK. Development and treatment of inflammatory cells and cytokines in spinal cord ischemia-reperfusion injury. Mediators Inflamm. 2013;2013:701970. - PMC - PubMed
    1. Smith PD, Puskas F, Meng XZ, Lee JH, Cleveland JC, Weyant MD, Fullerton DA, Reece TB. The evolution of Chemokine release supports a bimodal mechanism of spinal cord ischemia and reperfusion injury. Circulation. 2013;126(suppl 1):S110–S117. - PubMed
    1. Kahn RA, Stone ME, Moskowita DM. Anesthetic consideration for descending thoracic aortic aneurysm repair. Semin Cardiothorac Vasc Anesth. 2007;11:205–223. doi: 10.1177/1089253207306098. - DOI - PubMed
    1. Patel VI, Ergul E, Conrad MF, Cambria M, LaMuraglia GM, Kwolek CJ, Brewster DC, Cambria RP. Continued favorable results with open surgical repair of type IV thoracoabdominal aortic aneurysms. J Vasc Surg. 2011;53:1492–1498. doi: 10.1016/j.jvs.2011.01.070. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources